Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Outcomes of penetrating keratoplasty following autologous cultivated limbal epithelial stem cell transplantation

Lookup NU author(s): Dr Gustavo Figueiredo, Dr Oliver Baylis, Professor Majlinda LakoORCiD, Professor Francisco FigueiredoORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Purpose: To investigate the outcomes of penetrating keratoplasty (PKP) following autologous cultivated limbal epithelial stem cell transplantation (CLET).Methods: A prospective, single centre, interventional cohort study investigating patients with unilateral total limbal stem cell deficiency (LSCD) treated with CLET who underwent PKP. Patients with confirmed corneal re-epithelialization > 6 months post-CLET, and with best-corrected visual acuity (BCVA) <0.3 logMAR were offered PKP. Outcome measures: CLET survival assessed by slit lamp, corneal impression cytology (CIC) and in vivo confocal microscopy (IVCM). Confirmation of corneal re-epithelialization by histological and immunocytochemical (ICC) examination of trephined corneal buttons. Mean change in best-corrected visual acuity (logMAR) following PKP and PKP survival at 12 months were calculated.Results: 20 patients underwent PKP. Mean time of PKP was 19 months (range 11–41 months, SD 7.26) post-CLET. Median follow-up time post-PKP was 15.0 months (range 1–32, SD 10.2). CIC and ICC of all corneas confirmed corneal re-epithelialization before PKP. Mean pre-PKP BCVA was 1.46 (range 0.3–2.7, SD 0.94) improving to a mean post-PKP BCVA of 0.74 (range 0–2.7, SD 0.87); mean improvement in BCVA post-PKP of 36 letters (95% CI 15.0-57.1, p=0.002). Kaplan-Meier mean graft survival was 90.9% (95% CI 50.8-98.7) at 12 months.Conclusions: We recommend a two-stage approach with CLET followed by PKP >12 months later. Patients experienced a significant improvement in BCVA following PKP. PKP did not have a detrimental effect on CLET survival. PKP survival post-CLET is better than that reported for high risk PKP.


Publication metadata

Author(s): Figueiredo GS, Salvador CB, Baylis O, Hardeep M, Lako M, Figueiredo FC

Publication type: Article

Publication status: Published

Journal: Stem Cells

Year: 2018

Volume: 36

Issue: 6

Pages: 925-931

Print publication date: 01/06/2018

Online publication date: 13/02/2018

Acceptance date: 05/02/2018

Date deposited: 01/02/2019

ISSN (print): 1066-5099

ISSN (electronic): 1549-4918

Publisher: AlphaMed Press Inc.

URL: https://doi.org/10.1002/stem.2803

DOI: 10.1002/stem.2803


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
G0900879Medical Research Council (MRC)

Share